Adicet Bio (ACET)
(Delayed Data from NSDQ)
$1.53 USD
+0.01 (0.66%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.52 -0.01 (-0.65%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.34 |
EPS Last Quarter | -0.33 |
Last EPS Surprise | 5.71% |
ABR | 1.75 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.35 |
Next Year | -1.74 |
EPS (TTM) | -2.08 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.00M | 5.00M | 15.00M | 25.00M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 5.00M | 5.00M | 15.00M | 25.00M |
Low Estimate | 5.00M | 5.00M | 15.00M | 25.00M |
Year ago Sales | 0.00M | 0.00M | 24.99M | 15.00M |
Year over Year Growth Est. | NA | NA | -39.98% | 66.67% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.34 | -0.37 | -1.35 | -1.74 |
# of Estimates | 4 | 4 | 3 | 4 |
Most Recent Consensus | -0.34 | -0.36 | -1.38 | -1.50 |
High Estimate | -0.27 | -0.29 | -1.22 | -0.89 |
Low Estimate | -0.37 | -0.43 | -1.44 | -3.33 |
Year ago EPS | -0.71 | -0.69 | -2.86 | -1.35 |
Year over Year Growth Est. | 52.11% | 46.38% | 52.80% | -29.32% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.34 | -0.37 | -1.35 | -1.74 |
7 Days Ago | -0.34 | -0.37 | -1.35 | -1.74 |
30 Days Ago | -0.34 | -0.37 | -1.35 | -1.74 |
60 Days Ago | -0.35 | -0.38 | -1.37 | -1.77 |
90 Days Ago | -0.35 | -0.38 | -1.37 | -1.77 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.34 | -0.37 | -1.35 | -1.74 |
Zacks Consensus Estimate | -0.34 | -0.37 | -1.35 | -1.74 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.33 | -0.35 | -0.69 | -0.71 | NA |
Estimate | -0.35 | -0.35 | -0.72 | -0.73 | NA |
Difference | 0.02 | 0.00 | 0.03 | 0.02 | 0.02 |
Surprise | 5.71% | 0.00% | 4.17% | 2.74% | 3.16% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more